Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

CSL Ltd

AUAUD
← Allo screener

CSL Ltd (US:CMXHF) — Biotechnology. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'azienda

Sito web
csl.com.au
Relazioni con gli investitori
investors.csl.com/
Settore
Healthcare · Biotechnology
Sede centrale
Melbourne, Australia
Amministratore delegato
Mr. Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A.
Dipendenti
29 000
Fondata
1994
Azioni in circolazione
479.88 Mln
Flottante
478.53 Mln
Capitalizzazione di mercato
87.08 Mld AUD
Insider
0.02%
Investitori istituzionali
38.27%
Descrizione

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company's therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery; and Alentis Therapeutics AG to develop and commercialise lixudebart for rare kidney and liver diseases. The company was formerly known as Commonwealth Serum Laboratories Limited and later changed its name to CSL Limited in October 1991. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Borse e ticker

BorsaTickerValutaPrezzoTipo
AU Australian Securities ExchangeCSL principaleAUD183.84 +1.31%azioni ordinarie
US USA StocksCMXHF OTCUSD126.03 -1.29%azioni ordinarie

Prezzo su 3 mesi

giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Nessun pagamento di dividendi trovato (controllato 09.10.2026). Probabilmente la società non distribuisce dividendi.

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
VANGUARD STAR FUNDS-Vang…1.49%7.16 Mln2026-07-31
VANGUARD TAX-MANAGED FUN…0.99%4.75 Mln2026-06-30
iShares Trust-iShares Co…0.75%3.6 Mln2026-08-31
Fidelity Concord Street…0.39%1.89 Mln2026-07-31
iShares Trust-iShares MS…0.36%1.72 Mln2026-08-31
J.P. Morgan Exch-Trd Fd.…0.3%1.45 Mln2026-07-31
Fidelity Salem Street TR…0.29%1.38 Mln2026-07-31
iShares Trust-iShares MS…0.28%1.35 Mln2026-08-31
VANGUARD Intl Eqy. INDEX…0.24%1.16 Mln2026-07-31
SCHWAB STRATEGIC TRUST-S…0.22%1.08 Mln2026-05-31
Pacer Advisors, Inc.0.08%369 7742026-06-30
Naylor (Gordon) (Directo…≈0.01%40 8192026-05-26
McKenzie (Paul F) (Chief…≈0.01%31 0532025-09-01
McNamee (Brian Anthony)…≈0.01%30 5612026-08-21
Linton (Joy) (Chief Fina…≈0%15 0962025-06-30
Watkins (Alison Mary) (I…≈0%6 9892026-08-21
Clark (Megan Elizabeth)…≈0%5 7182025-08-22
Schmeltz (Andy) (Other E…≈0%5 0672025-06-30
Hewson (Carolyn Judith)…≈0%4 1312026-08-21
Price (Cameron Bruce) (I…≈0%3 5592026-08-21
Daniels (Brian M.D.) (No…≈0%3 4002025-11-18